project id: TCGA-CHOL; case submitter id: TCGA-ZH-A8Y5; analyte type: DNA; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.85; age at index: 69; days to birth: -25268; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1943; age at diagnosis: 25268; ajcc pathologic m: M1; ajcc pathologic n: N1; ajcc pathologic stage: Stage IVB; ajcc pathologic t: T3; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1229.0; icd 10 code: C22.1; last known disease status: not reported; morphology: 8160/3; primary diagnosis: Cholangiocarcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Intrahepatic bile duct; synchronous malignancy: No; tissue or organ of origin: Intrahepatic bile duct; tumor grade: Not Reported; year of diagnosis: 2012; alcohol history: Not Reported; is ffpe: false; days to collection: 622; days to sample procurement: 0; initial weight: 240.0; portion submitter id: TCGA-ZH-A8Y5-01A-11; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 60.0;